查看购物车
  • Traditional Chinese
  • English
  • Japanese
食物过敏市场 - 全球及区域分析：依药物类别、国家、地区 - 分析与预测（2025-2035 年）
市场调查报告书
商品编码
1729047

食物过敏市场 - 全球及区域分析：依药物类别、国家、地区 - 分析与预测（2025-2035 年）

Food Allergy Market - A Global and Regional Analysis: Focus on Drug Class, Country, and Region - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 100 Pages | 商品交期: 1-5个工作天内

价格

食物过敏发病率的上升、消费者意识的增强以及诊断和治疗方法的技术进步是推动食物过敏市场成长的主要因素。

食物过敏是世界性的重大问题，影响数百万人，导致对有效治疗方案的需求日益增加。

当免疫系统将无害的食物蛋白质误认为有害时，就会发生食物过敏。症状从轻微到危及生命不等，凸显了有效治疗和预防措施的必要性。免疫疗法和其他生技药品的进步在改善患者预后方面发挥重要作用。

市场生命週期阶段

食物过敏市场正处于发展阶段，对口服免疫疗法、生物製药和基因改造产品等新治疗方案进行了大量投资，旨在降低患者对过敏原的敏感度。从症状治疗到预防性护理的转变标誌着市场生命週期的关键点。

全球食物过敏市场按药物类别细分，每类药物针对食物过敏的不同方面。抗组织胺作为治疗轻微症状的药物很受欢迎，有助于维持稳定的市场需求。用于控制发炎的类固醇和有助于缓解呼吸道症状的β2-促效剂也是重要的细分市场，由于它们在控制食物过敏症状方面的互补作用，预计会出现适度增长。

北美占据全球食物过敏市场的最大份额，其中美国贡献巨大。

需求——驱动因素与限制因素

全球食物过敏市场受以下几个关键因素驱动：

  • 全球儿童和成人食物过敏的增加可能会推动对预防和治疗措施的需求
  • 预计对研发的更多关注将极大地促进对先进过敏护理产品的需求
  • 医疗支出和政府基础设施投资的增加将推动食物过敏市场的成长

限制：

  • 由于缺乏标准化的诊断标准，关于食物过敏的流行和管理的证据有限。
  • 检测结果的延迟和对大量血液样本的需求（尤其是儿童的情况）可能会阻碍市场的成长。
  • 治疗期间出现严重副作用的风险

产品/创新策略：报告重点介绍了食物过敏治疗和诊断服务的主要趋势，以帮助公司针对食物过敏患者进行生物製药、免疫疗法和精准药物的创新。

竞争策略：食品过敏市场竞争激烈，製药公司、医疗保健提供者和食品製造商可以利用本报告了解市场趋势、竞争对手和新机会，从而获得优势。

主要市场参与企业及竞争格局

本报告中介绍的公司是根据专家见解挑选出来的，并根据公司覆盖范围、产品系列和市场渗透率进行评估。全球食物过敏市场的主要企业包括製药公司、医疗保健提供者和食品製造商。

本报告研究了全球食物过敏市场，概述了市场以及药物类别、国家和地区的趋势以及参与市场的公司概况。

目录

第一章 全球食物过敏市场：产业展望

  • 市场概况与生态系统
  • 食物过敏的流行病学分析
    • 美国
    • 欧盟5国
    • 其他地区
  • 市场趋势
  • 临床试验
    • 爱别
  • 监理格局分析
    • 美国法律要求与框架
    • 欧盟法律要求和框架
    • 亚太地区的法律要求与框架
    • 其他国家的法律要求和框架
  • 市场动态

2. 全球食物过敏市场（依药物类别，百万美元，2023-2035 年）

  • 肾上腺素
  • 抗组织胺药
  • 类固醇
  • 其他的

3. 全球食物过敏市场（按地区，百万美元，2023-2035 年）

  • 北美洲
  • 欧洲
  • 亚太地区

4. 全球食物过敏市场－竞争基准化分析与公司概况

  • 竞争格局
    • 各公司主要策略及发展
    • 关键进展
  • 公司简介
    • Novartis Pharmaceuticals
    • F. Hoffmann-La Roche Ltd
    • DBV Technologies
    • Vedanta Biosciences, Inc
    • Regeneron Pharmaceuticals
    • Camallergy

第五章调查方法

Product Code: BHL2872SA

Global Food Allergy Market: Overview

Rising incidences of food allergies, growing awareness among consumers, and technological advancements in diagnostic and treatment methods are the primary drivers of market growth. Food allergies are a significant concern globally, affecting millions of individuals and leading to a growing demand for effective treatment options.

Food allergies occur when the immune system mistakenly identifies a harmless food protein as harmful. Symptoms can range from mild to life-threatening, highlighting the need for effective treatments and preventive measures. Advances in immunotherapy and other biologics are playing an important role in improving patient outcomes.

Market Lifecycle Stage

The food allergy market is in an evolving phase with substantial investment in new treatment options, such as oral immunotherapy, biologics, and genetically engineered products aimed at desensitizing patients to allergens. This shift from symptom management to more preventive treatments marks a pivotal point in the market's lifecycle.

Market Segmentation for the Global Food Allergy Market

Segmentation 1: by Drug Class

  • Epinephrine
  • Antihistamines
  • Steroids
  • Others

The global food allergy market is segmented by drug class, with each class addressing different aspects of food allergies. Antihistamines as a popular treatment for mild symptoms, contributing to consistent market demand. Steroids, used for managing inflammation, and Beta-2-agonists, which help alleviate respiratory symptoms, are also important segments, with moderate growth expected driven by their complementary roles in managing food allergy symptoms.

Segmentation 2: by Region

  • North America
  • Europe
  • Asia-Pacific

North America holds the largest share in the global food allergy market, with the U.S. being a major contributor.

Demand - Drivers and Limitations

The global food allergy market is driven by several key factors:

  • The global rise in food allergies among children and adults is likely to drive higher demand for preventive and therapeutic measures
  • A stronger focus on research and development is expected to significantly contribute to the demand for advanced allergy care products
  • Increased healthcare spending and government investment in infrastructure are boosting the growth of the food allergy market

Limitations:

  • The lack of standardized diagnostic criteria limits the evidence on food allergy prevalence and management
  • Delays in test results and the need for large blood samples, especially in children, can stifle market growth
  • Risk of severe adverse reactions during treatment

How Can This Report Add Value to an Organization?

Product/Innovation Strategy: This report highlights key trends in food allergy treatment and diagnostic services, helping companies innovate in biologics, immunotherapy, and precision medicine tailored to food allergy sufferers.

Competitive Strategy: The food allergy market is highly competitive, and pharmaceutical companies, healthcare providers, and food manufacturers can use this report to stay ahead by understanding market trends, competitors, and emerging opportunities.

Key Market Players and Competition Synopsis

The companies profiled in this report are selected based on expert insights, evaluating company coverage, product portfolio, and market penetration. Leading players in the global food allergy market include pharmaceutical companies, healthcare providers, and food manufacturers.

Table of Contents

Executive Summary

Scope of Study

Definition

Inclusion and Exclusion Criteria

1. Global Food Allergy Market: Industry Outlook

  • 1.1 Market Overview and Ecosystem
  • 1.2 Epidemiological Analysis of Food Allergy
    • 1.2.1 U.S.
    • 1.2.2 EU5
    • 1.2.3 Rest-of-the-World
  • 1.3 Market Trends
  • 1.4 Clinical Trials
    • 1.4.1 By Phase
  • 1.5 Regulatory Landscape Analysis
    • 1.5.1 Legal Requirement and Framework in U.S.
    • 1.5.2 Legal Requirement and Framework in E.U.
    • 1.5.3 Legal Requirement and Framework in Asia-Pacific
    • 1.5.4 Legal Requirement and Framework in Rest-of-the-World
  • 1.6 Market Dynamics
    • 1.6.1 Impact Analysis
    • 1.6.2 Market Drivers
    • 1.6.3 Market Restraints
    • 1.6.4 Market Opportunities

2. Global Food Allergy Market, by Drug Class, $Million, 2023-2035

  • 2.1 Epinephrine
  • 2.2 Antihistamines
  • 2.3 Steroids
  • 2.4 Others

3. Global Food Allergy Market, by Region, $Million, 2023-2035

  • 3.1 North America
    • 3.1.1 Key Findings
    • 3.1.2 Market Dynamics
    • 3.1.3 Market Sizing and Forecast
      • 3.1.3.1 North America Food Allergy Market (by Country)
        • 3.1.3.1.1 U.S.
  • 3.2 Europe
    • 3.2.1 Key Findings
    • 3.2.2 Market Dynamics
    • 3.2.3 Market Sizing and Forecast
      • 3.2.3.1 Europe Food Allergy Market (by Country)
        • 3.2.3.1.1 Germany
        • 3.2.3.1.2 France
        • 3.2.3.1.3 Italy
        • 3.2.3.1.4 U.K.
  • 3.3 Asia-Pacific
    • 3.3.1 Key Findings
    • 3.3.2 Market Dynamics
    • 3.3.3 Market Sizing and Forecast
      • 3.3.3.1 Asia-Pacific Food Allergy Market (by Country)
        • 3.3.3.1.1 Japan

4. Global Food Allergy Market - Competitive Benchmarking and Company Profiles

  • 4.1 Competitive Landscape
    • 4.1.1 Key Strategies and Developments by Company
      • 4.1.1.1 Funding Activities
      • 4.1.1.2 Mergers and Acquisitions
      • 4.1.1.3 Regulatory Approvals
      • 4.1.1.4 Partnerships, Collaborations and Business Expansions
    • 4.1.2 Key Developments Analysis
  • 4.2 Company Profiles
    • 4.2.1 Novartis Pharmaceuticals
      • 4.2.1.1 Company Overview
      • 4.2.1.2 Product Portfolio
      • 4.2.1.3 Target Customers / End Users
      • 4.2.1.4 Key Personnels
      • 4.2.1.5 Analyst View
    • 4.2.2 F. Hoffmann-La Roche Ltd
      • 4.2.2.1 Company Overview
      • 4.2.2.2 Product Portfolio
      • 4.2.2.3 Target Customers / End Users
      • 4.2.2.4 Key Personnels
      • 4.2.2.5 Analyst View
    • 4.2.3 DBV Technologies
      • 4.2.3.1 Company Overview
      • 4.2.3.2 Product Portfolio
      • 4.2.3.3 Target Customers / End Users
      • 4.2.3.4 Key Personnels
      • 4.2.3.5 Analyst View
    • 4.2.4 Vedanta Biosciences, Inc
      • 4.2.4.1 Company Overview
      • 4.2.4.2 Product Portfolio
      • 4.2.4.3 Target Customers / End Users
      • 4.2.4.4 Key Personnels
      • 4.2.4.5 Analyst View
    • 4.2.5 Regeneron Pharmaceuticals
      • 4.2.5.1 Company Overview
      • 4.2.5.2 Product Portfolio
      • 4.2.5.3 Target Customers / End Users
      • 4.2.5.4 Key Personnels
      • 4.2.5.5 Analyst View
    • 4.2.6 Camallergy
      • 4.2.6.1 Company Overview
      • 4.2.6.2 Product Portfolio
      • 4.2.6.3 Target Customers / End Users
      • 4.2.6.4 Key Personnels
      • 4.2.6.5 Analyst View

5. Research Methodology

List of Figures

  • Figure: Global Food Allergy Market, Coverage
  • Figure: Global Food Allergy Market, Key Trends, Impact Analysis
  • Figure: Global Food Allergy Market, Competitive Landscape, January 2022-April 2025

List of Tables

  • Table: Global Food Allergy Market, Dynamics and Impact Analysis
  • Table: Global Food Allergy Market, Regulatory Landscape
  • Table: Global Food Allergy Market, (by Drug Class), $Million, 2023-2035
  • Table: Global Food Allergy Market, (by Region), $Million, 2023-2035